Publication: Re: Risk of hbv reactivation in hbsag negative and antihbc igg positive patients receiving biologic therapy
dc.contributor.author | KANİ, HALUK TARIK | |
dc.contributor.author | KARABACAK, MURAT | |
dc.contributor.author | CÖMERT ÖZER, ELİF | |
dc.contributor.author | ABACAR, KEREM YİĞİT | |
dc.contributor.author | KUTLUĞ AĞAÇKIRAN, SEDA | |
dc.contributor.author | SEVİK, GİZEM | |
dc.contributor.author | ALİBAZ ÖNER, FATMA | |
dc.contributor.author | İNANÇ, GÜZİDE NEVSUN | |
dc.contributor.author | ATAGÜNDÜZ, MEHMET PAMİR | |
dc.contributor.author | ÖZEN ALAHDAB, YEŞİM | |
dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
dc.contributor.author | ATUĞ, ÖZLEN | |
dc.contributor.authors | Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., ABACAR K. Y., KUTLUĞ AĞAÇKIRAN S., SEVİK G., Aslan R., et al. | |
dc.date.accessioned | 2023-03-28T05:55:58Z | |
dc.date.available | 2023-03-28T05:55:58Z | |
dc.date.issued | 2023-03-01 | |
dc.identifier.citation | Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., ABACAR K. Y., KUTLUĞ AĞAÇKIRAN S., SEVİK G., Aslan R., et al., "RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy", The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.34, sa.3, ss.310, 2023 | |
dc.identifier.doi | 10.5152/tjg.2023.237002 | |
dc.identifier.endpage | 310 | |
dc.identifier.issn | 2148-5607 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 310 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150295043&origin=inward | |
dc.identifier.uri | https://hdl.handle.net/11424/287903 | |
dc.identifier.volume | 34 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Medicine | |
dc.subject | Internal Medicine Sciences | |
dc.subject | Internal Diseases | |
dc.subject | Gastroenterology and Hepatology | |
dc.subject | Health Sciences | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Clinical Medicine (MED) | |
dc.subject | CLINICAL MEDICINE | |
dc.subject | GASTROENTEROLOGY & HEPATOLOGY | |
dc.subject | Gastroenteroloji | |
dc.subject | Gastroenterology | |
dc.title | Re: Risk of hbv reactivation in hbsag negative and antihbc igg positive patients receiving biologic therapy | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | 8aa6f1bc-8715-4701-a22f-e673406239d9 | |
local.indexed.at | PUBMED | |
local.indexed.at | SCOPUS | |
relation.isAuthorOfPublication | f579a504-d81f-4c37-bdff-0090ba545178 | |
relation.isAuthorOfPublication | f235ab25-6c30-4942-9c83-bc13ec55a7b4 | |
relation.isAuthorOfPublication | f5c8997f-364f-4c70-baaa-96fbdffa6af9 | |
relation.isAuthorOfPublication | 55769942-746f-4108-9df0-b79d2d29b3bc | |
relation.isAuthorOfPublication | e7b1d6df-2f4a-45d9-b0f5-6021ac29d858 | |
relation.isAuthorOfPublication | 258cefab-765e-448a-b6ea-6105a1aa1fe5 | |
relation.isAuthorOfPublication | e995a136-8c56-4192-bebe-fe522b567ef1 | |
relation.isAuthorOfPublication | c963a17b-4775-4dd7-8db7-ea072cc49ef1 | |
relation.isAuthorOfPublication | 324d1d0f-ecfe-4b31-b5b9-1884a093b669 | |
relation.isAuthorOfPublication | 9e3fe3fa-13ef-422b-8e25-64a7665b4126 | |
relation.isAuthorOfPublication | 07a34d26-21f3-475d-bd36-152d6c659370 | |
relation.isAuthorOfPublication | 675c29e9-bab9-401b-aed1-9248ae6eb6db | |
relation.isAuthorOfPublication.latestForDiscovery | f579a504-d81f-4c37-bdff-0090ba545178 |
Files
Original bundle
1 - 1 of 1